Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Suspended 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Burkitt Lymphoma 14Lymphoma, Large B-Cell, Diffuse 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma, Follicular 7Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 5Wilms Tumor 3Sarcoma, Ewing 3Rhabdomyosarcoma 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Non-Hodgkin 3Lymphoma, B-Cell 3Lymphoma 3Plasmablastic Lymphoma 2Neoplasms 2Medulloblastoma 2Lymphoproliferative Disorders 2Lymphoma, T-Cell 2Lymphoma, Mantle-Cell 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia 2Ganglioneuroblastoma 2Down Syndrome 2Sarcoma 1Rhabdomyosarcoma, Embryonal 1Rhabdomyosarcoma, Alveolar 1Rhabdoid Tumor 1Osteosarcoma 1Neuroblastoma 1Multi-centric Castleman's Disease 1Malignant mesenchymal tumor 1

Interventions

Specimen Handling 5Biopsy 5Magnetic Resonance Spectroscopy 4Cyclophosphamide 3sodium-iodide symporter 2ruxolitinib 2duvelisib 2cemiplimab 2X-Rays 2Vincristine 2Prednisone 2Photons 2Immunoglobulin G 2Etoposide 2Doxorubicin 2Disulfides 2prednylidene 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1deltacortene 1carmustine, poliferprosan 20 drug combination 1Stem Cell Transplantation 1Standard of Care 1Practice Guidelines as Topic 1Peripheral Blood Stem Cell Transplantation 1Oxaliplatin 1Nivolumab 1Melphalan 1Leukapheresis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Lymphoma, T-Cell × Vincristine × 30 days × Clear all
NCT07278856 2026-06-05

Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell Lymphomas

City of Hope Medical Center

Phase 1 Recruiting
20 enrolled
Lymphoid

Lymphoma, T-Cell

NCT04803201 2026-06-02

Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma

Alliance for Clinical Trials in Oncology

Phase 2 Suspended
170 enrolled
Lymphoid

Immunoblastic Lymphadenopathy, Lymphoma, T-Cell, Enteropathy-Associated T-Cell Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡